X4 Pharmaceuticals, Inc - FORM S-1 - EX-23.1 - October 20, 2017

Attached files

file filename
EX-10.31 - EX-10.31 - X4 Pharmaceuticals, Incd427310dex1031.htm
EX-10.39 - EX-10.39 - X4 Pharmaceuticals, Incd427310dex1039.htm
S-1 - S-1 - X4 Pharmaceuticals, Incd427310ds1.htm
EX-21.1 - EX-21.1 - X4 Pharmaceuticals, Incd427310dex211.htm
EX-10.41 - EX-10.41 - X4 Pharmaceuticals, Incd427310dex1041.htm
EX-10.40 - EX-10.40 - X4 Pharmaceuticals, Incd427310dex1040.htm
EX-10.38 - EX-10.38 - X4 Pharmaceuticals, Incd427310dex1038.htm
EX-10.37 - EX-10.37 - X4 Pharmaceuticals, Incd427310dex1037.htm
EX-10.36 - EX-10.36 - X4 Pharmaceuticals, Incd427310dex1036.htm
EX-10.35 - EX-10.35 - X4 Pharmaceuticals, Incd427310dex1035.htm
EX-10.34 - EX-10.34 - X4 Pharmaceuticals, Incd427310dex1034.htm
EX-10.33 - EX-10.33 - X4 Pharmaceuticals, Incd427310dex1033.htm
EX-10.32 - EX-10.32 - X4 Pharmaceuticals, Incd427310dex1032.htm
EX-10.30 - EX-10.30 - X4 Pharmaceuticals, Incd427310dex1030.htm
EX-10.29 - EX-10.29 - X4 Pharmaceuticals, Incd427310dex1029.htm
EX-10.28 - EX-10.28 - X4 Pharmaceuticals, Incd427310dex1028.htm
EX-10.27 - EX-10.27 - X4 Pharmaceuticals, Incd427310dex1027.htm
EX-10.26 - EX-10.26 - X4 Pharmaceuticals, Incd427310dex1026.htm
EX-10.25 - EX-10.25 - X4 Pharmaceuticals, Incd427310dex1025.htm
EX-10.24 - EX-10.24 - X4 Pharmaceuticals, Incd427310dex1024.htm
EX-10.23 - EX-10.23 - X4 Pharmaceuticals, Incd427310dex1023.htm
EX-10.22 - EX-10.22 - X4 Pharmaceuticals, Incd427310dex1022.htm
EX-10.21 - EX-10.21 - X4 Pharmaceuticals, Incd427310dex1021.htm
EX-10.20 - EX-10.20 - X4 Pharmaceuticals, Incd427310dex1020.htm
EX-10.19 - EX-10.19 - X4 Pharmaceuticals, Incd427310dex1019.htm
EX-10.18 - EX-10.18 - X4 Pharmaceuticals, Incd427310dex1018.htm
EX-10.17 - EX-10.17 - X4 Pharmaceuticals, Incd427310dex1017.htm
EX-10.16 - EX-10.16 - X4 Pharmaceuticals, Incd427310dex1016.htm
EX-10.15 - EX-10.15 - X4 Pharmaceuticals, Incd427310dex1015.htm
EX-10.14 - EX-10.14 - X4 Pharmaceuticals, Incd427310dex1014.htm
EX-10.13 - EX-10.13 - X4 Pharmaceuticals, Incd427310dex1013.htm
EX-10.12 - EX-10.12 - X4 Pharmaceuticals, Incd427310dex1012.htm
EX-10.11 - EX-10.11 - X4 Pharmaceuticals, Incd427310dex1011.htm
EX-10.10 - EX-10.10 - X4 Pharmaceuticals, Incd427310dex1010.htm
EX-10.9 - EX-10.9 - X4 Pharmaceuticals, Incd427310dex109.htm
EX-10.8 - EX-10.8 - X4 Pharmaceuticals, Incd427310dex108.htm
EX-10.7 - EX-10.7 - X4 Pharmaceuticals, Incd427310dex107.htm
EX-10.6 - EX-10.6 - X4 Pharmaceuticals, Incd427310dex106.htm
EX-10.5 - EX-10.5 - X4 Pharmaceuticals, Incd427310dex105.htm
EX-10.4 - EX-10.4 - X4 Pharmaceuticals, Incd427310dex104.htm
EX-10.3 - EX-10.3 - X4 Pharmaceuticals, Incd427310dex103.htm
EX-10.2 - EX-10.2 - X4 Pharmaceuticals, Incd427310dex102.htm
EX-10.1 - EX-10.1 - X4 Pharmaceuticals, Incd427310dex101.htm
EX-4.1 - EX-4.1 - X4 Pharmaceuticals, Incd427310dex41.htm
EX-3.4 - EX-3.4 - X4 Pharmaceuticals, Incd427310dex34.htm
EX-3.3 - EX-3.3 - X4 Pharmaceuticals, Incd427310dex33.htm
EX-3.2 - EX-3.2 - X4 Pharmaceuticals, Incd427310dex32.htm
EX-3.1 - EX-3.1 - X4 Pharmaceuticals, Incd427310dex31.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of Arsanis, Inc. of our report dated August 10, 2017 relating to the financial statements, which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

 

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts

October 20, 2017

X4 Pharmaceuticals, Inc Reports